SCHEMBL22553799

SCHEMBL22553799

Cc1cnc2[nH]cc(-c3cncc(-c4ccc(N5CCCC5=O)cc4)c3)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD38 P28907 1/20 0.42
DYRK1A Q13627 5/20 0.41
IL2 P60568 3/20 0.41
MAP4K1 Q92918 3/20 0.41
DYRK1B Q9Y463 3/20 0.41
NTRK1 P04629 4/20 0.40
KIT P10721 2/20 0.40
PRKAB2 O43741 1/20 0.40
PRKAG1 P54619 1/20 0.40
PRKAA2 P54646 1/20 0.40
PRKAA1 Q13131 1/20 0.40
PRKAG3 Q9UGI9 1/20 0.40
PRKAG2 Q9UGJ0 1/20 0.40
PRKAB1 Q9Y478 1/20 0.40
CLK1 P49759 4/20 0.40
PIK3CA P42336 1/20 0.40
NPC1 O15118 1/20 0.40
PKM P14618 1/20 0.39
AXL P30530 2/20 0.39
SGK1 O00141 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22553811 0.88 JAK2 (0.46) CD38DYRK1AIL2MAP4K1DYRK1B
SCHEMBL22553722 0.86 MAP4K1 (0.40) CD38DYRK1AIL2MAP4K1DYRK1B
SCHEMBL22553858 0.86 CD38 (0.45) CD38DYRK1ADYRK1BNTRK1KIT
SCHEMBL30730850 0.86 CD38 (0.45) CD38DYRK1ADYRK1BNTRK1KIT
SCHEMBL22553926 0.85 ROCK2 (0.47) DYRK1ADYRK1BPRKAB2PRKAG1PRKAA2
SCHEMBL22553948 0.85 CAMKK2 (0.45) CD38DYRK1ADYRK1BNTRK1PRKAB2
SCHEMBL22553730 0.85 DYRK1A (0.40) CD38DYRK1AIL2MAP4K1DYRK1B
SCHEMBL22554043 0.85 MAP4K1 (0.48) DYRK1AMAP4K1DYRK1BPRKAB2PRKAG1
SCHEMBL22570987 0.84 DYRK1A (0.39) CD38DYRK1ADYRK1BNTRK1KIT
SCHEMBL22553851 0.80 ROCK2 (0.41) CD38PRKAB2PRKAG1PRKAA2PRKAA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2024-03-05 US claimed
EP-3728230-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS Ravenna Pharmaceuticals, Inc. (US) 2020-10-28 EP claimed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US claimed
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2024-03-05 US disclosed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US disclosed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS PIP5K1A, PIP5K1B, PIP5K1C CD38 1967/4885DYRK1A 334/4885IL2 4525/4885
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors PIP5K1A, PIP5K1B, PIP5K1C CD38 1967/4885DYRK1A 334/4885IL2 4525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.